Clinical trial
A Phase II Trial of CUDC-907 in Patients With Metastatic and Locally Advanced Thyroid Cancer
NCT03002623 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Trial of CUDC-907 in Patients With Metastatic and Locally Advanced Thyroid Cancer
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- December 22, 2016
- Completion date
- February 12, 2018
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
differentiated thyroid cancer, poorly differentiated and undifferentiated thyroid cancer, thyroid neoplasms